pharmaphorum5y
Shield Therapeutics soars on FDA approval of iron deficiency drug
The London-based company said the FDA had approved its lead product Ferracru/Accrufer (ferric maltol) in a market that could be worth $1 billion annually. The FDA approved the product for ...